{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/CAPL/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-18T15:51:41.171Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9986,"canonical_name":"CrossAmerica Partners LP","cik":"0001538849","uei":null,"lei":null,"duns":null,"ticker":"CAPL"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":21},"count":21,"timeline":[{"ts":"2026-08-05","kind":"sec.filing","form_type":"10-Q","title":"10-Q — CrossAmerica Partners LP — 2026-08-05","url_slug":"/sec/cik-0001538849/10-q/0001193125-26-335346","accession_number":"0001193125-26-335346","importance":45},{"ts":"2026-08-05","kind":"sec.filing","form_type":"8-K","title":"8-K — CrossAmerica Partners LP — 2026-08-05","url_slug":"/sec/cik-0001538849/8-k/0001193125-26-335332","accession_number":"0001193125-26-335332","importance":35},{"ts":"2026-07-24","kind":"sec.filing","form_type":"4","title":"4 — CrossAmerica Partners LP — 2026-07-24","url_slug":"/sec/cik-0001538849/4/0001538849-26-000047","accession_number":"0001538849-26-000047","importance":30},{"ts":"2026-07-24","kind":"sec.filing","form_type":"4","title":"4 — CrossAmerica Partners LP — 2026-07-24","url_slug":"/sec/cik-0001538849/4/0001538849-26-000049","accession_number":"0001538849-26-000049","importance":30},{"ts":"2026-07-24","kind":"sec.filing","form_type":"4","title":"4 — CrossAmerica Partners LP — 2026-07-24","url_slug":"/sec/cik-0001538849/4/0001538849-26-000051","accession_number":"0001538849-26-000051","importance":30},{"ts":"2026-07-24","kind":"sec.filing","form_type":"4","title":"4 — CrossAmerica Partners LP — 2026-07-24","url_slug":"/sec/cik-0001538849/4/0001538849-26-000053","accession_number":"0001538849-26-000053","importance":30},{"ts":"2026-07-24","kind":"sec.filing","form_type":"4","title":"4 — CrossAmerica Partners LP — 2026-07-24","url_slug":"/sec/cik-0001538849/4/0001538849-26-000055","accession_number":"0001538849-26-000055","importance":30},{"ts":"2026-07-24","kind":"sec.filing","form_type":"4","title":"4 — CrossAmerica Partners LP — 2026-07-24","url_slug":"/sec/cik-0001538849/4/0001538849-26-000057","accession_number":"0001538849-26-000057","importance":30},{"ts":"2026-07-23","kind":"sec.insider.m","reporter":"Kelso Thomas E","title":null,"shares":3154,"price_per_share":null,"usd_value":0,"security_title":"Common Units","importance":15},{"ts":"2026-07-23","kind":"sec.insider.m","reporter":"Valosky Kenneth G","title":null,"shares":3154,"price_per_share":null,"usd_value":0,"security_title":"Common Units","importance":15},{"ts":"2026-07-23","kind":"sec.insider.m","reporter":"Kim Mickey","title":null,"shares":3154,"price_per_share":null,"usd_value":0,"security_title":"Common Units","importance":15},{"ts":"2026-07-23","kind":"sec.insider.m","reporter":"Gannon Justin A.","title":null,"shares":3154,"price_per_share":null,"usd_value":0,"security_title":"Common Units","importance":15},{"ts":"2026-07-23","kind":"sec.insider.m","reporter":"Topper Joseph V. Jr.","title":"","shares":3154,"price_per_share":null,"usd_value":0,"security_title":"Common Units","importance":15},{"ts":"2026-07-23","kind":"sec.insider.m","reporter":"Reilly John B. III","title":null,"shares":3154,"price_per_share":null,"usd_value":0,"security_title":"Common Units","importance":15},{"ts":"2026-07-21","kind":"sec.filing","form_type":"8-K","title":"8-K — CrossAmerica Partners LP — 2026-07-21","url_slug":"/sec/cik-0001538849/8-k/0001193125-26-310448","accession_number":"0001193125-26-310448","importance":35},{"ts":"2026-07-21","kind":"sec.filing","form_type":"4","title":"4 — CrossAmerica Partners LP — 2026-07-21","url_slug":"/sec/cik-0001538849/4/0001538849-26-000035","accession_number":"0001538849-26-000035","importance":30},{"ts":"2026-07-21","kind":"sec.filing","form_type":"4","title":"4 — CrossAmerica Partners LP — 2026-07-21","url_slug":"/sec/cik-0001538849/4/0001538849-26-000037","accession_number":"0001538849-26-000037","importance":30},{"ts":"2026-07-21","kind":"sec.filing","form_type":"4","title":"4 — CrossAmerica Partners LP — 2026-07-21","url_slug":"/sec/cik-0001538849/4/0001538849-26-000039","accession_number":"0001538849-26-000039","importance":30},{"ts":"2026-07-21","kind":"sec.filing","form_type":"4","title":"4 — CrossAmerica Partners LP — 2026-07-21","url_slug":"/sec/cik-0001538849/4/0001538849-26-000041","accession_number":"0001538849-26-000041","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"8-K","title":"8-K — CrossAmerica Partners LP — 2026-07-16","url_slug":"/sec/cik-0001538849/8-k/0001193125-26-306100","accession_number":"0001193125-26-306100","importance":35},{"ts":"2026-06-29","kind":"sec.form144","reporter":"Charles Nifong","title":"Director","shares":4251,"usd_value":92500,"security_title":"Common","approx_sale_date":"2026-05-11","accession_number":"0001628280-26-045959","importance":40.01849997}]}